In a recent announcement, Abbott’s @ketogrillbakery revealed that they are actively working on solutions for their Lingo biosensor to measure additional key biomarkers, including ketones and lactate. While a specific launch date for these new features has not yet been established, the company encourages users to stay tuned for updates through their social media channels and official website.
Key Takeaways
- Abbott is expanding the capabilities of its Lingo biosensor.
- New biomarkers to be measured include ketones and lactate.
- No official launch date has been announced yet.
- Users are encouraged to follow Abbott on social media for updates.
What Is Lingo?
Lingo is a cutting-edge biosensor developed by Abbott that allows users to monitor their glucose levels continuously. This innovative device streams glucose data directly to users’ smartphones, providing real-time insights into how their diet and lifestyle choices affect their glucose levels.
The Importance Of Biomarkers
Biomarkers are critical indicators of various physiological states in the body. Measuring ketones and lactate can provide valuable insights into metabolic health, athletic performance, and overall well-being.
- Ketones: These are produced when the body burns fat for energy instead of carbohydrates. Monitoring ketone levels can be particularly beneficial for individuals following ketogenic diets or those managing diabetes.
- Lactate: This is a byproduct of anaerobic metabolism and can indicate how well the body is performing during exercise. High levels of lactate can signal fatigue and the need for recovery.
Future Prospects
The addition of ketone and lactate measurements to the Lingo biosensor could significantly enhance its utility for users interested in optimizing their health and performance. As the demand for personalized health monitoring continues to grow, Abbott’s innovations in this space are timely and relevant.
Stay Updated
For those interested in the latest developments regarding Lingo and its new features, Abbott recommends following their social media channels and checking their website regularly. This will ensure that users are among the first to know when new capabilities are launched, allowing them to take full advantage of the advancements in health monitoring technology.
In conclusion, Abbott’s commitment to expanding the functionality of the Lingo biosensor reflects a broader trend in health technology towards more comprehensive and personalized monitoring solutions. As they work towards integrating new biomarkers, users can look forward to enhanced insights into their health and wellness journey.
